19.02.2013 Views

Notice: This CMS-approved document has been submitted - Philips ...

Notice: This CMS-approved document has been submitted - Philips ...

Notice: This CMS-approved document has been submitted - Philips ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>CMS</strong>-1403-FC<br />

sleep tests, we shall prohibit payment to the supplier of<br />

the CPAP device when such supplier, or its affiliate<br />

defined as a person or organization that is related to<br />

another person or organization through a compensation<br />

arrangement or some type of ownership, is directly or<br />

indirectly the provider or the interpreter of the<br />

unattended out of facility sleep test that is used to<br />

diagnose a Medicare beneficiary with OSA.<br />

We considered several options. We considered whether<br />

a narrower prohibition could reasonably accomplish the<br />

purposes of this regulation at this time. Exceptions for<br />

providers that offer integrated disease management models<br />

were considered. We also considered allowing an exception<br />

for nationally accredited disease management programs but<br />

we are unaware of any current model that would encompass<br />

accreditation for both OSA diagnosis and CPAP supply under<br />

a single accreditation certificate.<br />

Therefore, we proposed to revise the durable medical<br />

equipment, prosthetics, orthotics, and supplies (DMEPOS)<br />

supplier enrollment safeguards set forth at §424.57 to<br />

protect the Medicare program and its beneficiaries from<br />

fraudulent or abusive practices that may be related to CPAP<br />

devices. We also proposed to add new definitions to<br />

paragraph (a) to define “Continuous positive airway<br />

730

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!